Genyuan Zhu

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index1.0kcitations33works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endoplasmic Reticulum Stress and Disease(17), Peptidase Inhibition and Analysis(10), Immunotherapy and Immune Responses(6), interferon and immune responses(5), Pancreatic function and diabetes(4)

Publications33 total

Data from STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
2023Open Access
Data from STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
2023Open Access
Supplementary Data (for Review only) from STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
2023Open Access
Supplementary Data (for Review only) from STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
2023Open Access
Data from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Methods from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Methods from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Tables 1 - 2 from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Tables 1 - 2 from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Figures 1 - 9 from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Data from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Supplementary Figures 1 - 9 from Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis
2023Open Access
Data from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
Supplementary Figure 1 from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
Data from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
Supplementary Figure Legend from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
Supplementary Figure Legend from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
Supplementary Figure 1 from A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
2023Open Access
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
Cancer Immunology Research·2019· 87 citedOpen Access
OMIP‐049: Analysis of Human Myelopoiesis and Myeloid Neoplasms
Cytometry Part A·2018· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Amy S. Lee(22), Zibo Li(18), Dezheng Dong(16), James J. Mulé(11), Parkash S. Gill(10), Ren Liu(9), Xiu‐Qing Li(9), Wenming Gao(9), Shiuan Wey(9), Satyajit K. Mitra(9), Valery Krasnoperov(9), Stan G. Louie(9), Peter S. Conti(9), Risheng Ye(9), Adam W. Mailloux(9), Susan Groshen(8), Rana Falahat(8), Yue Zhou(8), Biquan Luo(7), Shigang Xiong(7)